Inhibition of Lung Squamous Cancer Target HMGCS1 Promotes Cellular Ferroptosis
10.3779/j.issn.1009-3419.2024.101.12
- VernacularTitle:抑制肺鳞癌靶点HMGCS1促进细胞铁死亡
- Author:
NI YINYUN
1
;
YANG YING
;
ZHANG LI
Author Information
1. 610000 成都,四川大学华西医院疾病分子网络前沿科学中心呼吸健康研究所
- Keywords:
Lung neoplasms;
HMGCS1;
Ferroptosis;
Hymeglusin
- From:
Chinese Journal of Lung Cancer
2024;27(5):330-336
- CountryChina
- Language:Chinese
-
Abstract:
Background and objective Targeted therapies are ineffective in lung squamous cancer(LUSC),and the low response rate of immunotherapy hampers its application in LUSC,so it is urgent to explore new strategies for LUSC treat-ment.Ferroptosis plays an important role in tumour suppression.The aim of this study was to investigate the role and mecha-nism of targeting 3-hydroxy-3-methylglutaryl-CoA synthase 1(HMGCS1)in regulating ferroptosis in LUSC cells,in order to provide a new research direction for LUSC therapy.Methods The expression of HMGCS1 in LUSC was analysed by The Cancer Genome Atlas(TCGA)and Clinical Proteomic Tumor Analysis Consortium(CPTAC)online databases;the relation-ship between HMGCS1 and survival time of lung cancer was analysed by the Kaplan-Meier Plotter online survival database;the expression level of HMGCS1 in LUSC tissues was verified by immunohistochemistry.After interfering with HMGCS1 expression by small interfering RNA(siRNA),cell activity and cell migration ability were detected by CCK8 and Transwell as-say;apoptosis was detected by flow cytometry after interfering with HMGCS1 or after treatment with the HMGCS1 inhibitor of hymeglusin;Fe2+,reactive oxygen species(ROS)and lipid peroxidation levels were detected by flow cytometry and high-content confocal fluorescence imaging systems,respectively in SKMES cells after inhibition of HMGCS1;and Western blot was performed to detect the expression of ACSL4,GPX4 and SLC7A11,which are markers of the ferroptosis pathway after in-hibition of HMGCS1.Results HMGCS1 mRNA and protein levels were significantly high in LUSC;siRNA interference with HMGCS1 expression inhibited the proliferative activity and migration ability of LUSC cells,but had no significant effect on apoptosis.Interference with HMGCS1 or treatment with the HMGCS1 inhibitor of hymeglusin significantly promoted intra-cellular Fe2+,ROS and lipid peroxidation levels in SKMES cells,and induced ferroptosis in LUSC cells;Western blot assay showed that inhibition of HMGCS1 significantly promoted the expression of ACSL4.Conclusion Inhibition of HMGCS1,a target of LUSC,promotes ferroptosis in lung cancer cells and provides a research basis for screening new therapeutic targets for LUSC.
